0001739614-24-000017.txt : 20240315
0001739614-24-000017.hdr.sgml : 20240315
20240315164829
ACCESSION NUMBER: 0001739614-24-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240313
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eckelman Brendan P.
CENTRAL INDEX KEY: 0001766433
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39452
FILM NUMBER: 24755561
MAIL ADDRESS:
STREET 1: C/O INHIBRX, INC.
STREET 2: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibrx, Inc.
CENTRAL INDEX KEY: 0001739614
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 824257312
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 795-4220
MAIL ADDRESS:
STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
wk-form4_1710535699.xml
FORM 4
X0508
4
2024-03-13
0
0001739614
Inhibrx, Inc.
INBX
0001766433
Eckelman Brendan P.
C/O INHIBRX, INC.
11025 NORTH TORREY PINES ROAD, SUITE 200
LA JOLLA
CA
92037
0
1
0
0
Chief Scientific Officer
0
Stock Option (right to buy)
33.63
2024-03-13
4
M
0
1898
35.3332
D
2031-01-15
Common Stock
1898
9177
D
Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
/s/ Kelly D. Deck, as attorney in fact for Brendan P. Eckelman
2024-03-15